Defendant is in the business of fractionating whole blood plasma into component parts, by use of refrigerated centrifuge machines, for ultimate transfusion into human beings. The value of the plasma in defendant's control at any one time is as much as $5 million. Defendant's processing agreement with Bayer, the principal supplier of plasma, requires defendant to maintain $5 million coverage for "casualty, spoilage, loss, theft, fire, damage or destruction to personal property...
Let's get started
Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.
- Updated daily.
- Uncompromising quality.
- Complete, Accurate, Current.